Assessment of cardiac electrical activity in patients with polycystic ovary syndrome: A systematic review and meta-analysis
Biomedicine Advances · 2025
DOI: 10.34172/bma.17 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Biomedicine Advances, 2025. Verfasst von Seyedeh-Tarlan Mirzohreh und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Polycystic ovary syndrome (PCOS) is a common endocrine disorder associated with metabolic disturbances, including insulin resistance and an increased risk of cardiovascular complications. This systematic review and meta-analysis, conducted following PRISMA guidelines, compared cardiac electrical activity in PCOS patients versus healthy controls. Databases (PubMed, Scopus, Web of Science, Cochrane) were searched using Joanna Briggs Institute (JBI) appraisal tools. Sixteen studies met inclusion criteria, with data categorized into atrial (P-wave) and ventricular (QT interval) electrical activity. Meta-analysis using RevMan and Comprehensive Meta-Analysis software revealed significant differences in atrial conduction. PCOS patients exhibited prolonged Pmax (mean difference=7.49; 95% CI [0.36, 14.63], P=0.04) and increased P dispersion (MD=10.74; 95% CI [5.96, 15.51], P
Zitieren
APA
Mirzohreh, S., & Heidari, F. (2025). Assessment of cardiac electrical activity in patients with polycystic ovary syndrome: A systematic review and meta-analysis. Biomedicine Advances. https://doi.org/10.34172/bma.17
Vancouver
Mirzohreh S, Heidari F. Assessment of cardiac electrical activity in patients with polycystic ovary syndrome: A systematic review and meta-analysis. Biomedicine Advances. 2025. doi:10.34172/bma.17
BibTeX
@article{Mirzohreh2025,
author = {Mirzohreh, Seyedeh-Tarlan and Heidari, Fariba},
title = {Assessment of cardiac electrical activity in patients with polycystic ovary syndrome: A systematic review and meta-analysis},
journal = {Biomedicine Advances},
year = {2025},
doi = {10.34172/bma.17}
}
EUVIMED